Kyntra Bio (MEX:KYNB) FFO


MEX:KYNB Kyntra Bio Inc MEX:KYNB
35 GF Score
Price MXN118.50
GF Value MXN94.05
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Kyntra Bio FFO?

FFO (Funds from operations) only applies to REITs.

MEX:KYNB
35GF Score
Kyntra Bio Inc MEX:KYNB
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kyntra Bio (MEX:KYNB) Overvalued in 2026?

Based on GuruFocus' analysis, Kyntra Bio stock appears to be overvalued. The current stock price of MXN118.50 is trading 26% above its estimated GF Value™ of MXN94.05. GuruFocus considers Kyntra Bio to be Modestly Overvalued.

Key valuation signals for MEX:KYNB:

  • FFO:
  • GF Value™: MXN94.05 vs. price of MXN118.50 (26% above fair value)
  • GF Score™: 35/100 with 8 warning signs

No single metric tells the full story. See the MEX:KYNB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kyntra Bio Business Description

Other Exchanges KYNB:USA0IL8:UK1FG0:Germany
Address 350 Bay Street, Suite 100, No. 6009, San Francisco, CA, USA, 94133
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
35GF Score

Get the complete analysis for MEX:KYNB

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN118.50
Price
MXN94.05
GF Value